Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Directorate Change

18 Dec 2014 07:00

RNS Number : 1143A
4imprint Group PLC
18 December 2014
 



18 December 2014

4imprint Group plc ("4imprint" or the "Group")

Board Succession Planning

4imprint, the leading international direct marketer of promotional products, today issues an announcement regarding its Board succession planning. 

Over the past three years, 4imprint has successfully disposed of its non-core businesses (Brand Addition and SPS) and has undertaken a substantial reduction and de-risking of its legacy Defined Benefit Pension Scheme.

The 4imprint Group (the "Group") now consists exclusively of its Direct Marketing business in the USA, comprising 96% of the Group's revenue, together with its small UK subsidiary, both managed from Oshkosh, Wisconsin. The Group's results are now reported in US Dollars.

Reflecting this evolution, the Board has decided the following succession plans:

With effect from 31 March 2015, Kevin Lyons-Tarr, the Chief Executive of the Direct Marketing business and an existing member of the Board will be appointed Chief Executive of 4imprint. Mr. Lyons-Tarr, who has been responsible for the growth of the Direct Marketing business since 2003, will continue to be based in the USA.

It has also been decided that 4imprint's Group Finance Director will in future also be based in the USA, although an appropriate plc accounting function, together with the Corporate Services Director and Company Secretary will be retained in the UK.

Gillian Davies, 4imprint's current Group Finance Director, has informed the Board that she does not wish to relocate to Oshkosh, Wisconsin. The Board has accepted Ms. Davies' decision and she will leave 4imprint on 31 March 2015, following a handover. The Board wishes to thank Ms. Davies for her substantial contribution as Group Finance Director to the reorganisation and growth of 4imprint since 2004 and to wish her well for the future.

David Seekings, who has been Chief Financial Officer of the Direct Marketing business since 2000 will, also with effect from 31 March 2015, be appointed to the Board as Group Finance Director of 4imprint. Mr. Seekings is a UK citizen, an Oxford University graduate and a Chartered Accountant who has worked very closely with Mr. Lyons-Tarr and has contributed significantly to the development of the Direct Marketing business.

At an appropriate point later in 2015, John Poulter, the Executive Chairman of 4imprint, will relinquish his executive duties and will become Non-Executive Chairman.

The Board intends to make an additional Non-Executive Director appointment in the New Year.

There are no disclosures required under Listing Rule 9.6.13 in respect of Mr. Seekings' appointment.

John Poulter, Chairman of 4imprint, said:

"Following the significant strategic development of 4imprint over the last few years, we have realigned the Board more closely to reflect our US bias.

"By promoting Kevin Lyons-Tarr and David Seekings to Group Board leadership positions, we have ensured continuity of management and recognition of their significant contributions to 4imprint's growth."

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 7299 7201

 

MHP Communications

Tel. + 44 (0) 20 3128 8100

John Poulter

Executive Chairman

 

 

Reg Hoare

Katie Hunt

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABCBDDBDBBGSR
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.